BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19116231)

  • 1. Influence of Slc11a1 (formerly Nramp1) on DSS-induced colitis in mice.
    Jiang HR; Gilchrist DS; Popoff JF; Jamieson SE; Truscott M; White JK; Blackwell JM
    J Leukoc Biol; 2009 Apr; 85(4):703-10. PubMed ID: 19116231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
    Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
    J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
    Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
    Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice.
    Sun X; Yamada H; Yoshihara K; Awaya A; Yoshikai Y
    Int Immunopharmacol; 2007 Jul; 7(7):928-36. PubMed ID: 17499195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice.
    Hans W; Schölmerich J; Gross V; Falk W
    Eur Cytokine Netw; 2000 Mar; 11(1):67-74. PubMed ID: 10705301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation.
    Xu Y; Hunt NH; Bao S
    Cell Res; 2008 Dec; 18(12):1220-9. PubMed ID: 19030026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextran sulphate sodium-induced colitis is ameliorated in interleukin 4 deficient mice.
    Stevceva L; Pavli P; Husband A; Ramsay A; Doe WF
    Genes Immun; 2001 Oct; 2(6):309-16. PubMed ID: 11607786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation.
    Sugimoto K; Ogawa A; Shimomura Y; Nagahama K; Mizoguchi A; Bhan AK
    Gastroenterology; 2007 Jul; 133(1):124-36. PubMed ID: 17631137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
    Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
    Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
    Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
    J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.
    Kim DJ; Kim KS; Song MY; Seo SH; Kim SJ; Yang BG; Jang MH; Sung YC
    Clin Immunol; 2012 Sep; 144(3):190-9. PubMed ID: 22836084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
    Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
    Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
    J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death.
    Da Silva AP; Pollett A; Rittling SR; Denhardt DT; Sodek J; Zohar R
    J Cell Physiol; 2006 Sep; 208(3):629-39. PubMed ID: 16741956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and function of interleukin-18 in mouse dextran sulfate sodium colitis].
    Wen ZH; Quyang Q; Zhang H; Yi ZH; Wang YF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):676-8. PubMed ID: 16235535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.
    Jauch D; Martin M; Schiechl G; Kesselring R; Schlitt HJ; Geissler EK; Fichtner-Feigl S
    Gut; 2011 Dec; 60(12):1678-86. PubMed ID: 21948944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
    Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
    J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis.
    Ghia JE; Blennerhassett P; El-Sharkawy RT; Collins SM
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G711-8. PubMed ID: 17673544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses.
    Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Iwakura Y; Yoshikai Y
    J Immunol; 2010 Dec; 185(12):7671-80. PubMed ID: 21068411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to experimental colitis depends on cytoprotective heat shock proteins in macrophage migration inhibitory factor null mice.
    Ohkawara T; Nishihira J; Ishiguro Y; Otsubo E; Nagai K; Takeda H; Kato M; Yoshiki T; Iwanaga T; Asaka M
    Immunol Lett; 2006 Nov; 107(2):148-54. PubMed ID: 17049622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.